CATNAP

Conditions: Clinical Diagnosis of Narcolepsy I or II

Type of Research: Observational
Principal Investigator: Michael Strunc MD

Study Specifications: Narcolepsy is a lifelong, debilitating neurological disorder, clinically characterized by a pentad of symptoms including excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic hallucinations, and disrupted nighttime sleep. There is little information in the literature regarding pediatric narcolepsy. CATNAP is an observational studying aiming to study the natural history, practices, and outcomes of pediatric narcolepsy. 

Email: CRU@chkd.org
Phone: (757) 668-5416

TAK-861-301

Conditions: Narcolepsy Type 1 

Type of Research: Prospective
Principal Investigator: Michael Strunc, MD

Study Specifications: 

The TAK-861-3001 trial will assess the effects of investigational drug TAK-861 on patients with diagnosed Type 1 Narcolepsy.

Email: CRU@chkd.org
Phone: (757) 668-5416